Top Qs
Timeline
Chat
Perspective
Invasive lobular carcinoma
Medical condition From Wikipedia, the free encyclopedia
Remove ads
Invasive lobular carcinoma (ILC) is breast cancer arising from the lobules of the mammary glands.[1] It accounts for 5–10% of invasive breast cancer.[2][3] Rare cases of this carcinoma have been diagnosed in men (see male breast cancer).[4]

Remove ads
Types
Summarize
Perspective
The histologic patterns include:[6][7][8]
- Histopathology of invasive lobular carcinoma (ILC), next to lobular carcinoma in situ (LCIS)
- Invasive lobular carcinoma demonstrating a predominantly lobular growth pattern
- Lobular breast cancer. Single file cells and cell nests.
- ILC may be subtle on low magnification (left). Higher magnification (right) shows invasive growth pattern and vesicular nuclei with prominent nucleoli.
Remove ads
Prognosis
Overall, the five-year survival rate of invasive lobular carcinoma was approximately 85% in 2003.[9]
Diagnosis
On mammography, ILC shows spiculated mass with ill-defined margins that has similar or lower density than surrounding breast tissues. This happens only at 44–65% of the time. Architectural distortion on surrounding breast tissues is only seen in 10–34% of the cases. It can be reported as benign in 8–16% of the mammography cases.[10]
Ultrasound has 68–98% sensitivity of detecting ILC. ILC shows irregular or angular mass with hypoechoic or heterogenous internal echoes, ill-defined or spiculated margins, and posterior acoustic shadowing.[10]
Loss of E-cadherin is common in lobular carcinoma but is also seen in other breast cancers.[11]
Treatment
Treatment includes surgery and adjuvant therapy.
References
External links
Wikiwand - on
Seamless Wikipedia browsing. On steroids.
Remove ads